Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E24.92 EPS (ttm)5.48 Insider Own0.07% Shs Outstand2.68B Perf Week-1.90%
Market Cap366.28B Forward P/E15.83 EPS next Y8.63 Insider Trans-1.90% Shs Float2.68B Perf Month-2.43%
Income14.97B PEG3.34 EPS next Q2.03 Inst Own68.80% Short Float0.50% Perf Quarter6.85%
Sales80.68B P/S4.54 EPS this Y-8.50% Inst Trans0.06% Short Ratio2.15 Perf Half Y6.92%
Book/sh23.45 P/B5.82 EPS next Y5.89% ROA0.90% Target Price144.32 Perf Year0.32%
Cash/sh6.76 P/C20.19 EPS next 5Y7.45% ROE2.10% 52W Range118.62 - 148.32 Perf YTD-2.26%
Dividend3.60 P/FCF39.32 EPS past 5Y7.10% ROI15.70% 52W High-7.93% Beta0.64
Dividend %2.64% Quick Ratio1.30 Sales past 5Y2.60% Gross Margin65.80% 52W Low15.12% ATR2.16
Employees134000 Current Ratio1.70 Sales Q/Q10.60% Oper. Margin22.10% RSI (14)46.41 Volatility2.35% 1.49%
OptionableYes Debt/Eq0.51 EPS Q/Q4.10% Profit Margin1.70% Rel Volume1.50 Prev Close133.95
ShortableYes LT Debt/Eq0.47 EarningsOct 16 BMO Payout572.60% Avg Volume6.22M Price136.56
Recom2.40 SMA20-1.58% SMA500.14% SMA2004.02% Volume9,326,768 Change1.95%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Oct-16-18 08:52PM  The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)
07:54PM  [$$] Prescription Drugs Power Johnson & Johnson Results The Wall Street Journal
07:54PM  [$$] Encouraging Test Results for Health-Care Giants The Wall Street Journal
07:47PM  Edited Transcript of JNJ earnings conference call or presentation 16-Oct-18 12:30pm GMT Thomson Reuters StreetEvents
07:20PM  Stocks can keep rallying as long as Fed doesn't keep push... CNBC Videos
07:01PM  Jim Cramer: An Absence of Negatives Is a Real Positive
06:37PM  Cramer: As long as the Fed doesn't keep pushing rate hike... CNBC Videos
06:11PM  Cramer: As long as the Fed doesn't keep pushing rate hikes, stocks can keep rallying CNBC
05:23PM  Stocks surge, recovering some recent losses; Dow climbs 547 Associated Press
05:00PM  3 Stocks for Warren Buffett Fans Motley Fool
04:56PM  What Happened in the Stock Market Today Motley Fool
04:52PM  Stocks Soar on Earnings Octane Investopedia
04:46PM  Stocks surge, recovering some recent losses; Dow climbs 547 Associated Press
04:30PM  UnitedHealth, Johnson & Johnson and Morgan Stanley jump Associated Press
04:11PM  Market focuses on revenue growth as the key to combating rising costs, interest rates CNBC
04:05PM  Dow Surges More Than 540 Points on Strong Bank Earnings; Nasdaq Gains 2.9%
03:12PM  Johnson & Johnson (JNJ) Q3 2018 Earnings Conference Call Transcript Motley Fool
03:01PM  Stock Market Storms Higher, But Can The Rally Be Trusted? Investor's Business Daily
01:43PM  Will Tuesday's Earnings Reports Inspire a Stock Market Rebound? Zacks
01:29PM  Johnson & Johnson Rises on Strong 3rd-Quarter Results
01:20PM  Wall Street Rises on Strong Earnings
01:17PM  A popular health-care fund is on pace for its best day since President Trump's election MarketWatch
12:13PM  Market gets back to basics with a rally that shows fundamentals still rule CNBC
11:55AM  J&J beats profit estimates, lifts outlook on pharma unit strength Reuters
11:46AM  [$$] Encouraging Test Results for Health-Care Giants The Wall Street Journal
11:31AM  Netflix Is Tonight's Big Report: Here's How I Would Play It
11:05AM  [$$] Prescription Drugs Power Johnson & Johnson Results The Wall Street Journal
11:05AM  Johnson & Johnson Looks Healthier Than Ever Motley Fool
10:54AM  Prescription drugs, lower taxes, power J&J 3Q beat Associated Press
10:39AM  Q3 Earnings Reports: MSFT, NFLX, GS, MS, UNH, JNJ Zacks
10:28AM  Johnson & Johnson Bumps Full-Year Earnings Guidance Higher After Solid Q3
10:26AM  Q3 Earnings Results Impress: GS, MS, UNH & More Zacks
10:08AM  Johnson & Johnson edges past profit estimates, lifts outlook Reuters
10:07AM  UPDATE 2-Johnson & Johnson edges past profit estimates, lifts outlook Reuters
10:04AM  J&J applauds U.S. proposal on drug prices in TV ads Reuters
09:52AM  J&J (JNJ) Beats Earnings & Sales Estimates in Q3, Ups View Zacks
09:26AM  Dow's earnings reporters providing a 92-point boost to futures' rally MarketWatch
09:08AM  [$$] Stocks to Watch: Goldman, Morgan, Walmart, U.S. Steel The Wall Street Journal
08:53AM  U.S. Stocks Set For Solid Open as Q3 Earnings Impress; Goldman Boosts Dow
07:55AM  Johnson & Johnson (JNJ) Surpasses Q3 Earnings and Revenue Estimates Zacks
07:54AM  Stocks making the biggest move premarket: MS, GS, UNH, JNJ, WMT & more CNBC
07:47AM  Netflix, Goldman Sachs, Paul Allen, Google and Ford - 5 Things You Must Know
07:30AM  US STOCKS-Futures rise on upbeat results from UnitedHealth, Morgan Stanley Reuters
07:02AM  Johnson & Johnson reports Q3 profit, revenue beats MarketWatch
06:47AM  Johnson & Johnson quarterly profit rises 4.5 percent Reuters
06:40AM  Johnson & Johnson Reports 2018 Third-Quarter Results: PR Newswire
06:30AM  Johnson & Johnson to Host Earnings Call ACCESSWIRE
06:14AM  Johnson & Johnson tops third-quarter earnings, revenue estimates CNBC
Oct-15-18 05:12PM  Johnson & Johnson CEO Discusses Drug Pricing Meredith Videos
03:53PM  5 Top Stock Trades for Tuesday: Trading Bank Earnings InvestorPlace
03:00PM  7 Stocks to Buy and Hold Through Any Market Selloff InvestorPlace
02:32PM  Johnson & Johnson Q3 Earnings Preview Benzinga
11:16AM  Drugmakers will soon talk about price in ads but not as explicitly as Trump administration wants CNBC
08:35AM  JPMorgan, Wells Fargo, Citigroup, Johnson & Johnson, Netflix and Schlumberger are part of Zacks Earnings Preview Zacks
Oct-12-18 06:11PM  Cramer's game plan: Increased volatility could turn positive with help from Trump, Fed CNBC
05:53PM  Banks Provide Positive Start to Q3 Earnings Season Zacks
02:31PM  This 1 Stock Could Send the Entire Healthcare Sector Soaring -- or Plunging Motley Fool
10:25AM  Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal Zacks
10:04AM  J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion Zacks
09:35AM  Is a Surprise Coming for Johnson & Johnson (JNJ) This Earnings Season? Zacks
09:01AM  Dow 30 Stock Roundup: Walgreens' Earnings Top, UTX Board OKs Dividend Hike Zacks
08:20AM  3 Big Pharma Stocks Racing Along the Road to China Motley Fool
08:12AM  Jury clears J&J of liability in New Jersey talc cancer case Reuters
Oct-11-18 03:58PM  Here's Why Arrowhead Pharmaceuticals Skyrocketed Almost 30% in September Motley Fool
03:25PM  Jury clears J&J of liability in New Jersey talc cancer case Reuters
10:21AM  J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings Zacks
Oct-10-18 05:45PM  Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know Zacks
11:38AM  5 Healthcare Stocks to Buy for Complete Portfolio Wellness InvestorPlace
10:35AM  J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study Zacks
10:23AM  Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates Zacks
Oct-09-18 04:11PM  4 Reasons to Be Wary of This Animal Health IPO Motley Fool
03:12PM  10 S&P 500 Stocks to Buy for the Long Term InvestorPlace
12:00PM  Orchestra BioMed Adds Three Industry Leaders to Strategic Advisory Board GlobeNewswire
10:45AM  ARWR Stock Sinks After Signing a Big Collaboration Deal InvestorPlace
10:30AM  Johnson & Johnson (JNJ) Q3 Earnings Preview: Here's What to Look Out For Zacks
10:05AM  Here's Why Geron Plummeted 69% in September Motley Fool
09:46AM  J&J's Stelara succeeds in chronic bowel disease study Reuters
Oct-08-18 06:05PM  Johnson & Johnson Offers an Attractive Investment Proposition
12:00PM  Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day PR Newswire
11:15AM  Are These Beaten-Down Clinical-Stage Biotech Stocks Buys? Motley Fool
09:25AM  Geron Stock: Buy, Sell, or Hold? Motley Fool
08:01AM  Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip? Motley Fool
Oct-05-18 01:12PM  8 Stocks to Buy That Will Never Go Out of Style InvestorPlace
11:30AM  J&J Inks Deal With Arrowhead for Promising Liver Candidate Zacks
10:22AM  MARKETS: Nike, McDonald's leading the Dow higher, as big banks get a bump Yahoo Finance Video
09:57AM  Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data Zacks
Oct-04-18 06:28PM  MARKETS: Don't freak out about today's selloff, but retail is still in trouble Yahoo Finance Video
02:49PM  J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion Reuters
02:24PM  7 Healthcare Stocks to Buy Right Now InvestorPlace
11:30AM  Stocks - Apple, Amazon Fall in Pre-market; Barnes & Noble Surges
10:57AM  Health-Care Stocks High Valuations May Not Be a Problem
10:12AM  Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug Benzinga
09:37AM  J&J's Phase III Data Shows Switch to its HIV Drug Beneficial Zacks
09:19AM  J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion Reuters
07:59AM  The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut Benzinga
07:52AM  UPDATE: Arrowhead Pharma stock surges 19% on news of $3.7 billion license agreement with Janssen MarketWatch
03:20AM  Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US Moody's
Oct-03-18 05:13PM  Platinum Equity completes $2B purchase of J&Js LifeScan American City Business Journals
11:14AM  Here's Why J&J (JNJ) is a Good Bet in a Troubled Market Zacks
10:23AM  Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM